< Back to scientific publications

Magazine 9.54

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First ItalianųoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Gennaro GD, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership

Date: 2022

Scope of interest: Epilepsy




You may also be interested in:

Magazine 13.2

Prognosis of untreated hepatocellular carcinoma.

Authors: Giannini EG et al.

Date: Jan 2015

Scope of interest: hepatological


Read details
Magazine

AntiemeticProphylaxis with NEPA (NETUPITANT/PALONOSETRON) and Dexamethasone to PreventChemotherapy-Induced Nausea and Vomiting (CINV) in Hodgkin’SLymphoma Naïve PatientsReceiving ABVD Regimen: A MulticenterPhaseIia Study

Authors: Daniela Nasso,Silvia Bolis, Elisabetta Abbruzzese, Ilaria Romano,Ida Provenzano Cristiano Tesei,Ida Provenzano, Maria Cantonetti

Date: 2020

Scope of interest: Haematology


Read details
Report/Poster of Convention/Congress Act

An unusual EEG pattern in the context of eclampsia complicated by reversible cerebral vasoconstriction syndrome

Authors: M. Fanella, F. Marinelli, D. Lavorato, V. Valli Fiore, L. Friello,V. Mistretta, M. Lauretti, F. Apponi, R. De Simone

Date: 2022

Scope of interest: Emergencies in neurology


Read details